Rodman, E. P. B., Emch, M. J., Hou, X., Bajaj, A., Pearson, N. A., John, A. J., . . . Hawse, J. R. Lestaurtinib’s antineoplastic activity converges on JAK/STAT signaling to inhibit treatment naïve and therapy resistant forms ovarian cancer. Nature Portfolio.
Chicago Style (17th ed.) CitationRodman, Esther P. B., et al. Lestaurtinib’s Antineoplastic Activity Converges on JAK/STAT Signaling to Inhibit Treatment Naïve and Therapy Resistant Forms Ovarian Cancer. Nature Portfolio.
MLA (9th ed.) CitationRodman, Esther P. B., et al. Lestaurtinib’s Antineoplastic Activity Converges on JAK/STAT Signaling to Inhibit Treatment Naïve and Therapy Resistant Forms Ovarian Cancer. Nature Portfolio.
Warning: These citations may not always be 100% accurate.